Brudno, J. N., Lam, N., Vanasse, D., Shen, Y., Rose, J. J., Rossi, J., Xue, A., Bot, A., Scholler, N., Mikkilineni, L., Roschewski, M., Dean, R., Cachau, R., Youkharibache, P., Patel, R., Hansen, B., Stroncek, D. F., Rosenberg, S. A., Gress, R. E., Kochenderfer, J. N. Safety and feasibility of anti-CD19 CAR T cells with…
Read MoreKakon, N., Luizaga, H., Pham, C., Bezabih, R., Elnour, H., Procter, J., Ping, J., Highfill, S., Stroncek, D. F., Panc, S. R. Comparable Postthaw CD34+ and CD3+ Cell Characteristics With Commercial and In-House Cryoprotectants: Commercial Favored for Ease of Use. Transfusion. 2019; 59(S3), 106A-107A. doi:10.1111/trf.15462
Read MoreChen, L. N., Collins‐Johnson, N., Sapp, N., Pickett, A., West, K., Stroncek, D. F., Panch, S. R. How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing? Transfusion. August 2019; 59 (8), 2506-2518. doi:10.1111/trf.15349
Read MoreStroncek, D., Mathew, A., & McKenna, D. Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care. Transfusion. 2019; 59(S1), 854-857. doi:10.1111/trf.14832
Read MoreStroncek, D., Mathew, A., & McKenna, D. Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care. Transfusion. 2019; 59(S1), 854-857. doi:10.1111/trf.14832
Read MoreGniadek, Garritsen, Stroncek, Szczepiorkowski, McKenna. Optimal Storage Conditions for Apheresis Research (OSCAR): a Biomedical Excellence for Safer Transfusion (BEST) Collaborative study. Transfusion. 2017 Dec 6. doi: 10.1111/trf.14429
Read MoreHerzog R, Nichols T, Su J, Zhang B, Sherman A, et al. Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce. Molecular Therapy (2016) DOI: http://dx.doi.org/10.1016/j.ymthe.2016.11.009
Read More